Skip to content
PubMed This is a summary of 10 peer-reviewed journal articles Updated
Medical Genetics

Is OPMD Hereditary? Understanding PABPN1 Inheritance

At a Glance

Yes, Oculopharyngeal Muscular Dystrophy (OPMD) is a hereditary condition caused by a mutation in the PABPN1 gene. It typically follows an autosomal dominant inheritance pattern, meaning a parent with OPMD has a 50% chance of passing the mutated gene to each of their children.

Yes, Oculopharyngeal Muscular Dystrophy (OPMD) is a hereditary condition, meaning it is passed down through families [1]. It is caused by a genetic mutation (a change in your DNA) in a specific gene called PABPN1 [2][3].

If you have OPMD, one of your primary concerns might be whether your family members—including your children and siblings—will also have the condition. In most cases, OPMD follows an autosomal dominant pattern of inheritance [2][1].

Understanding Autosomal Dominant Inheritance

“Autosomal dominant” is a medical term that describes how a genetic trait is passed through a family [1].

  • Autosomal means the mutated gene is located on a non-sex chromosome. This means both men and women are equally likely to inherit the condition and pass it on.
  • Dominant means that inheriting just one copy of the mutated gene (from either parent) is enough to eventually develop the disease.

Because you have two copies of every gene—one inherited from each parent—in the dominant form of OPMD, you have one mutated PABPN1 gene and one normal PABPN1 gene.

Your Children’s Chances

When you have a child, you randomly pass on just one of these two genes. This means:

  • There is a 50% chance you will pass on the mutated PABPN1 gene to each child [1][4]. If they receive this gene, they will eventually develop OPMD later in life.
  • There is a 50% chance you will pass on the normal gene to each child [1][4]. If they receive this gene, they will not develop OPMD, and they cannot pass it to their future children.

This 50/50 chance applies to each pregnancy independently, much like a coin flip. Having one child who inherits the condition does not change the chances for your next child.

Parents and Siblings

Because OPMD is hereditary, you likely inherited the mutation from one of your parents, even if they were never formally diagnosed. If one of your parents had the mutation, each of your brothers and sisters also has a 50% chance of having inherited it [5].

Rare Forms of OPMD

While the vast majority of OPMD cases are autosomal dominant, there is an extremely rare autosomal recessive form of the disease [6]. In an autosomal recessive pattern, a person must inherit two copies of the mutated gene (one from each parent) to develop the condition. If you have the recessive form, your children would typically be “carriers” of the gene—meaning they have one copy of the mutated gene but do not show symptoms—unless your partner is also a carrier [6]. Your doctor can help clarify which form runs in your family based on genetic testing.

Genetic Testing and Family Planning

Because OPMD affects the whole family tree, genetic counseling is highly recommended [7][8].

A genetic counselor is a healthcare professional trained in medical genetics who can help you and your family navigate the medical and emotional aspects of a diagnosis. They can help:

  • Explain genetic test results: They can clarify the details of your PABPN1 mutation. The mutation involves extra repetitions of a specific DNA sequence (called GCG repeats), which act somewhat like a “genetic stutter.” The number of these repeats can sometimes provide clues about when symptoms might begin and how severe they might be [9][10].
  • Assess family risk: They can map out your family tree to identify siblings, children, or other relatives who might be at risk [5].
  • Guide family conversations: Sharing a genetic diagnosis can be daunting. Counselors can provide tools and strategies for discussing this news with your children and relatives.
  • Discuss testing options for adult family members: Because OPMD usually doesn’t cause symptoms until your 40s, 50s, or 60s, adult family members may choose to have predictive genetic testing to find out if they carry the mutation before symptoms appear [5]. Medical guidelines generally recommend against testing minors for adult-onset conditions like OPMD, allowing children to make their own choice when they reach adulthood.
  • Explore family planning for your adult children: Because you were likely diagnosed later in life, your adult children might be the ones thinking about starting families. If they have inherited the gene, a genetic counselor can explain reproductive options to prevent passing it on. This may include preimplantation genetic diagnosis (PGD), where embryos created through in vitro fertilization (IVF) are tested for the OPMD mutation before being implanted [7][8].

Deciding whether to undergo genetic testing is deeply personal. A genetic counselor can support you and your family in weighing the emotional and practical implications of knowing your genetic status.

Common questions in this guide

Is Oculopharyngeal Muscular Dystrophy passed down in families?
Yes, OPMD is a hereditary condition passed down through families. It is caused by a specific genetic mutation in the PABPN1 gene.
What is the chance of passing OPMD to my children?
In most cases, OPMD follows an autosomal dominant inheritance pattern. This means there is a 50 percent chance of passing the mutated PABPN1 gene to each of your children, regardless of their gender.
What does the PABPN1 gene test tell me?
A genetic test looks for extra repetitions of a specific DNA sequence in the PABPN1 gene. The number of these repeats can sometimes provide clues about when your symptoms might begin and how severe they might be.
Can genetic testing prevent passing OPMD to future generations?
Yes, adult children carrying the gene can explore reproductive options like preimplantation genetic diagnosis (PGD). This allows embryos created through in vitro fertilization (IVF) to be tested for the OPMD mutation before implantation.
Should my young children be tested for the OPMD mutation?
Medical guidelines generally recommend against predictive testing for minors when dealing with adult-onset conditions like OPMD. This allows children to make their own informed choices about genetic testing once they reach adulthood.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Does my specific genetic test result confirm the typical autosomal dominant form of OPMD?
  2. 2.Based on the number of repeats in my PABPN1 gene, what can we anticipate regarding my disease progression?
  3. 3.Can you refer my family and me to a genetic counselor who has experience with adult-onset muscular dystrophies?
  4. 4.What resources or letters can you provide to help me explain this diagnosis and the need for genetic counseling to my siblings and children?
  5. 5.If my adult children or siblings want to be tested for the OPMD mutation, what is the best process for them to do so?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (10)
  1. 1

    Inhibition of myostatin improves muscle atrophy in oculopharyngeal muscular dystrophy (OPMD).

    Harish P, Malerba A, Lu-Nguyen N, et al.

    Journal of cachexia, sarcopenia and muscle 2019; (10(5)):1016-1026 doi:10.1002/jcsm.12438.

    PMID: 31066242
  2. 2

    [Haplotype Analysis of Oculopharyngeal Muscular Dystrophy (OPMD) Locus in Yakutia].

    Marusin AV, Kurtanov KhA, Maksimova NR, et al.

    Genetika 2016; (52(3)):376-84.

    PMID: 27281858
  3. 3

    Recurrent Pneumonia in a Patient With Oculopharyngeal Muscular Dystrophy (OPMD) due to GCN Expansion in the PABPN1 Gene: A Diagnostic Challenge.

    Mañana Valdés C, Arias Guillén M, Moris de la Tassa G

    Open respiratory archives 2026; (8(2)):100580 doi:10.1016/j.opresp.2026.100580.

    PMID: 41676387
  4. 4

    Oculopharyngeal Muscular Dystrophy: A Case Report From Puerto Rico.

    Menendez Sepulveda JA, Izquierdo N

    Cureus 2024; (16(7)):e65766 doi:10.7759/cureus.65766.

    PMID: 39082045
  5. 5

    Oculopharyngeal Muscular Dystrophy and Inherited Retinal Dystrophy in Bukhara Jews Due to Linked Mutations in the PABPN1 and NRL Genes.

    Braverman I, Blumen SC, Newman H, et al.

    Genetic testing and molecular biomarkers 2017; (21(7)):450-453 doi:10.1089/gtmb.2016.0429.

    PMID: 28590779
  6. 6

    Dropped-head in recessive oculopharyngeal muscular dystrophy.

    Garibaldi M, Pennisi EM, Bruttini M, et al.

    Neuromuscular disorders : NMD 2015; (25(11)):869-72.

    PMID: 26494409
  7. 7

    Characterization of PABPN1 expansion mutations in a large cohort of Mexican patients with oculopharyngeal muscular dystrophy (OPMD).

    Cruz-Aguilar M, Guerrero-de Ferran C, Tovilla-Canales JL, et al.

    Journal of investigative medicine : the official publication of the American Federation for Clinical Research 2017; (65(3)):705-708 doi:10.1136/jim-2016-000184.

    PMID: 27980005
  8. 8

    Oculopharyngeal muscular dystrophy, myasthenia gravis, systemic lupus erythematosus: overlap and interactions.

    M Barbosa J, A Pereira P

    BMJ case reports 2024; (17(11)) doi:10.1136/bcr-2024-262742.

    PMID: 39532331
  9. 9

    Correlation between PABPN1 genotype and disease severity in oculopharyngeal muscular dystrophy.

    Richard P, Trollet C, Stojkovic T, et al.

    Neurology 2017; (88(4)):359-365 doi:10.1212/WNL.0000000000003554.

    PMID: 28011929
  10. 10

    Clinical and genetic features of a large homogeneous cohort of oculopharyngeal muscular dystrophy patients from the Canary Islands.

    Alonso-Pérez J, de León Hernández JC, Pérez-Pérez H, et al.

    European journal of neurology 2022; (29(5)):1488-1495 doi:10.1111/ene.15252.

    PMID: 35112761

This page provides educational information about the genetics and inheritance of OPMD. It is not a substitute for professional medical advice or personalized genetic counseling.

Get notified when new evidence is published on Oculopharyngeal muscular dystrophy.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.